18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis of quaternarya-amino acid-based arginase inhibitors via the Ugi reaction.
Institutes For Pharmaceutical Discovery
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitors.
Institutes For Pharmaceutical Discovery
Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injury.
Institutes For Pharmaceutical Discovery
Binding ofa,a-disubstituted amino acids to arginase suggests new avenues for inhibitor design.
Drexel University
Chemical similarities and differences among inhibitors of nitric oxide synthase, arginase and dimethylarginine dimethylaminohydrolase-1: Implications for the design of novel enzyme inhibitors modulating the nitric oxide pathway.
Flinders University
Recent advances in small molecule based cancer immunotherapy.
Southern Medical University
If small molecules immunotherapy comes, can the prime be far behind?
Zhejiang University
Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores.
Sichuan University
Novel Arginase Inhibitors for Treating Cancer and Respiratory Inflammatory Diseases.
Smith, Gambrell & Russell
Purine derivatives and the use thereof as medicament
Boehringer Ingelheim International